Study Notes on Generalized Anxiety Disorder (GAD)

Clinical Description of Generalized Anxiety Disorder (GAD)

  • Definition of GAD

    • Generalized Anxiety Disorder is characterized by intense, uncontrollable, unfocused, chronic, and continuous worry that is distressing and unproductive.

    • Accompanied by physical symptoms such as tenseness, irritability, and restlessness.

  • DSM-5 Criteria for GAD

    • Patients must experience excessive anxiety and worry (apprehensive expectation) for at least six months.

    • The worrying must occur more days than not.

    • It is difficult for patients to control or turn off the worry process.

    • Distinction from normal worrying: Most individuals can set their worries aside temporarily, whereas individuals with GAD cannot.

Physical Symptoms of GAD

  • Muscle tension

  • Mental agitation (Brown, Marten, & Barlow, 1995)

  • Susceptibility to fatigue (due to chronic muscle tension)

  • Irritability

  • Difficulty sleeping (Campbell-Sills & Brown, 2010)

  • Difficulty focusing, leading to a rapid switching of attention from crisis to crisis.

    • Common Worries in GAD

  • Individuals with GAD worry excessively about minor, everyday life events.

  • When questioned about worrying excessively about minor things, 100% of individuals with GAD responded affirmatively, contrasting with 50% for other anxiety disorders (Barlow, 2002).

  • Common anxiety focuses include:

    • Misfortunes to their children

    • Family health

    • Job responsibilities

    • Minor issues like household chores and punctuality.

    • Worries among Children and Older Adults

  • Children with GAD often fuss over academic, athletic, or social performance and family issues (Furr et al., 2009; Weems et al., 2000).

  • Older adults tend to focus on health issues (Wetherell et al., 2010; Beck & Averill, 2004).

Statistics on GAD

  • Prevalence

    • GAD affects approximately 3.1% of the population in a given year (Kessler et al., 2005) and 5.7% at some point during their lifetime (Kessler et al., 2005).

  • Treatment-Seeking Behavior

    • GAD is less commonly treated than panic disorder; only about 10% of patients in anxiety clinics meet the criteria for GAD compared to 30-50% for panic disorder.

    • This disparity suggests that many individuals with GAD turn to primary care doctors instead of specialized anxiety treatment (Roy-Byrne & Katon, 2000; Wittchen, 2002).

  • Gender and Demographic Differences

    • Epidemiological studies indicate that twice as many females are diagnosed with GAD compared to males (Grant et al., 2005).

    • An exception occurs in South Africa, where GAD is more prevalent among males.

    • The disorder's prevalence is lower among Asian, Hispanic, and Black adults compared to White individuals (Grant et al., 2005).

  • Age of Onset

    • GAD can begin in early adulthood, typically in response to life stressors, but it is often associated with a gradual onset.

    • The median age of onset is 31 (Kessler et al., 2005), though many have experienced anxiety throughout their lives.

    • GAD displays a chronic course, with symptoms waxing and waning.

    • Particularly prevalent in older adults, with reported rates as high as 10% in that age group (Wittchen et al., 1994; Byers et al., 2010).

  • Medications in Older Adults

    • High prevalence of benzodiazepine use among older adults; 5.2% of U.S. adults used them in 2008, increasing with age (Olfson et al., 2015).

    • Risks with benzodiazepines include cognitive impairment and increased fall risk (Barlow, 2002).

Causes of GAD

  • Biological Vulnerability

    • Evidence suggests a genetic contribution to GAD.

    • It's the predisposition to anxiety rather than GAD itself that is inherited.

    • Anxiety sensitivity, the fear of anxiety-related sensations, has shown heritability (Davies et al., 2015).

  • Physiological Differences

    • Individuals with GAD do not display the high stress response seen in panic disorders; they show decreased physiological arousal during stress (Borkovec & Hu, 1990; Roemer & Orsillo, 2013).

    • They exhibit lower cardiac vagal tone, contributing to autonomic inflexibility (Hofmann et al., 2005).

  • Chronic Muscle Tension

    • Individuals with GAD are characterized by persistent muscle tension (Andrews et al., 2010).

Cognitive Processes in GAD

  • Threat Sensitivity

    • Individuals with GAD demonstrate heightened sensitivity to perceived threats (Roemer & Orsillo, 2013).

    • They focus more readily on potential threats, often due to early traumatic experiences that foster a belief in the world's danger and their inability to cope.

  • Autonomic Restriction

    • Borkovec identifies that GAD individuals experience intense cognitive engagement without effective emotional processing of associated imagery (Borkovec et al., 2004).

    • This lack of engagement with emotional imagery results in chronic worry but hinders resolution and coping.

Treatment of GAD

  • Common Treatments

    • Benzodiazepines provide short-term relief but carry risks such as cognitive and motor impairment, particularly problematic for older adults.

    • Psychological treatments often show equal short-term benefits to medications but surpass them in long-term effectiveness (Barlow, Allen, & Basden, 2007; Roemer & Orsillo, 2013).

  • Cognitive-Behavioral Therapy (CBT)

    • Developed to help patients process anxiety during therapy, confront threatening thoughts and images, and utilize coping techniques (Craske & Barlow, 2006).

    • Demonstrated success in diverse settings, including primary care (Rollman et al., 2005).

  • Innovative Psychological Approaches

    • Newer treatments include mindfulness-based therapies aimed at increasing tolerance to anxiety (Hofmann et al., 2010).

    • Studies are showing promising results, particularly for children and older adults (Albano & Hack, 2004; Beck & Stanley, 1997).

  • Long-Term Outcomes

    • Irene's case serves as an example of successful treatment through CBT, leading to continued management of anxiety with minor tranquilizers as needed.

  • Meta-Cognitions

    • Research indicates that addressing patients’ maladaptive beliefs about worrying shows promise in treatment (Wells et al., 2010).

Conclusion: Understanding GAD involves deep insights into its causes, symptoms, and appropriate treatment approaches that combine medication and psychological therapies effectively.